Cargando…

The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis

People with Down syndrome (DS) have a neurodevelopmentally distinct brain and invariably developed amyloid neuropathology by age 50. This cross-sectional study aimed to provide a detailed account of DS brain morphology and the changes occuring with amyloid neuropathology. Forty-six adults with DS un...

Descripción completa

Detalles Bibliográficos
Autores principales: Annus, Tiina, Wilson, Liam R., Acosta-Cabronero, Julio, Cardenas-Blanco, Arturo, Hong, Young T., Fryer, Tim D., Coles, Jonathan P., Menon, David K., Zaman, Shahid H., Holland, Anthony J., Nestor, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391869/
https://www.ncbi.nlm.nih.gov/pubmed/28192686
http://dx.doi.org/10.1016/j.neurobiolaging.2017.01.009
_version_ 1783229350681772032
author Annus, Tiina
Wilson, Liam R.
Acosta-Cabronero, Julio
Cardenas-Blanco, Arturo
Hong, Young T.
Fryer, Tim D.
Coles, Jonathan P.
Menon, David K.
Zaman, Shahid H.
Holland, Anthony J.
Nestor, Peter J.
author_facet Annus, Tiina
Wilson, Liam R.
Acosta-Cabronero, Julio
Cardenas-Blanco, Arturo
Hong, Young T.
Fryer, Tim D.
Coles, Jonathan P.
Menon, David K.
Zaman, Shahid H.
Holland, Anthony J.
Nestor, Peter J.
author_sort Annus, Tiina
collection PubMed
description People with Down syndrome (DS) have a neurodevelopmentally distinct brain and invariably developed amyloid neuropathology by age 50. This cross-sectional study aimed to provide a detailed account of DS brain morphology and the changes occuring with amyloid neuropathology. Forty-six adults with DS underwent structural and amyloid imaging—the latter using Pittsburgh compound B (PIB) to stratify the cohort into PIB-positive (n = 19) and PIB-negative (n = 27). Age-matched controls (n = 30) underwent structural imaging. Group differences in deep gray matter volumetry and cortical thickness were studied. PIB-negative people with DS have neurodevelopmentally atypical brain, characterized by disproportionately thicker frontal and occipitoparietal cortex and thinner motor cortex and temporal pole with larger putamina and smaller hippocampi than controls. In the presence of amyloid neuropathology, the DS brains demonstrated a strikingly similar pattern of posterior dominant cortical thinning and subcortical atrophy in the hippocampus, thalamus, and striatum, to that observed in non-DS Alzheimer's disease. Care must be taken to avoid underestimating amyloid-associated morphologic changes in DS due to disproportionate size of some subcortical structures and thickness of the cortex.
format Online
Article
Text
id pubmed-5391869
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53918692017-05-01 The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis Annus, Tiina Wilson, Liam R. Acosta-Cabronero, Julio Cardenas-Blanco, Arturo Hong, Young T. Fryer, Tim D. Coles, Jonathan P. Menon, David K. Zaman, Shahid H. Holland, Anthony J. Nestor, Peter J. Neurobiol Aging Regular Article People with Down syndrome (DS) have a neurodevelopmentally distinct brain and invariably developed amyloid neuropathology by age 50. This cross-sectional study aimed to provide a detailed account of DS brain morphology and the changes occuring with amyloid neuropathology. Forty-six adults with DS underwent structural and amyloid imaging—the latter using Pittsburgh compound B (PIB) to stratify the cohort into PIB-positive (n = 19) and PIB-negative (n = 27). Age-matched controls (n = 30) underwent structural imaging. Group differences in deep gray matter volumetry and cortical thickness were studied. PIB-negative people with DS have neurodevelopmentally atypical brain, characterized by disproportionately thicker frontal and occipitoparietal cortex and thinner motor cortex and temporal pole with larger putamina and smaller hippocampi than controls. In the presence of amyloid neuropathology, the DS brains demonstrated a strikingly similar pattern of posterior dominant cortical thinning and subcortical atrophy in the hippocampus, thalamus, and striatum, to that observed in non-DS Alzheimer's disease. Care must be taken to avoid underestimating amyloid-associated morphologic changes in DS due to disproportionate size of some subcortical structures and thickness of the cortex. Elsevier 2017-05 /pmc/articles/PMC5391869/ /pubmed/28192686 http://dx.doi.org/10.1016/j.neurobiolaging.2017.01.009 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular Article
Annus, Tiina
Wilson, Liam R.
Acosta-Cabronero, Julio
Cardenas-Blanco, Arturo
Hong, Young T.
Fryer, Tim D.
Coles, Jonathan P.
Menon, David K.
Zaman, Shahid H.
Holland, Anthony J.
Nestor, Peter J.
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title_full The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title_fullStr The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title_full_unstemmed The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title_short The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
title_sort down syndrome brain in the presence and absence of fibrillar β-amyloidosis
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5391869/
https://www.ncbi.nlm.nih.gov/pubmed/28192686
http://dx.doi.org/10.1016/j.neurobiolaging.2017.01.009
work_keys_str_mv AT annustiina thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT wilsonliamr thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT acostacabronerojulio thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT cardenasblancoarturo thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT hongyoungt thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT fryertimd thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT colesjonathanp thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT menondavidk thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT zamanshahidh thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT hollandanthonyj thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT nestorpeterj thedownsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT annustiina downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT wilsonliamr downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT acostacabronerojulio downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT cardenasblancoarturo downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT hongyoungt downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT fryertimd downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT colesjonathanp downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT menondavidk downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT zamanshahidh downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT hollandanthonyj downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis
AT nestorpeterj downsyndromebraininthepresenceandabsenceoffibrillarbamyloidosis